namaste | free shipping on orders $75+

MethylDetox Profile Genetic Testing, Certified Health Coach, Ellie Schneck
MethylDetox Profile Genetic Testing, Certified Health Coach, Ellie Schneck

Genetic Testing Individual Genes

Regular price $119.00 Sale

Individual Genes that can be tested:

  • MTR
  • MTRR
  • COMT
  • AHCY


Patient test results are provided both in the context of the methylation pathway and personalized commentary. Commentary includes supplementation recommendations for personalized treatment. Throughout treatment, homocysteine testing is recommended to monitor patient outcomes.


Individuals with a manifestation and/or family history of:

  • Cardiovascular disease
  • Hypertension, coronary artery disease, stroke
  • Neurodegenerative disorders
  • Poor drug clearance
  • Polypharmacy
  • Multiple chemical sensitivity (MCS)
  • Chronic fatigue syndrome (CFS)
  • Chronic metabolic disorders
  • Metabolic syndrome
  • Diabetes
  • Kidney or liver disease
  • Musculoskeletal disorders
  • Autism spectrum disorder
  • Depression/anxiety
  • Insomnia
  • Alzheimer’s Disease


More than 50% of people are affected by genetic mutations in the methylation pathway. Standard MTHFR genotyping only evaluates folic acid metabolism. The MethylDetox Profile makes it easy to understand the complicated methylation process by giving comprehensive insights into the functional status of the methylation pathway.

The MethylDetox Profile includes genetic markers involved in methylation and homocysteine metabolism provided in a detailed lab report with personalized commentary. Additionally, continued homocysteine testing enables easy monitoring of patient progress.

Genetic variations in this pathway are associated with elevated homocysteine levels, impaired methylation processes and limited detoxification capacity. As a result, these SNPs (single nucleotide polymorphisms) may contribute to accelerated aging, certain chronic diseases like cardiovascular disease and neurodegenerative disorders, impaired gene-regulation, poor drug clearance, and impaired neurotransmitter metabolism.